Literature DB >> 11831625

Protein standardization III: Method optimization basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry.

S Blirup-Jensen1.   

Abstract

Quantitative protein determinations in routine laboratories are today most often carried out using automated instruments. However, slight variations in the assay principle, in the programming of the instrument or in the reagents may lead to different results. This has led to the prerequisite of method optimization and standardization. The basic principles of turbidimetry and nephelometry are discussed. The different reading principles are illustrated and investigated. Various problems are identified and a suggestion is made for an integrated, fast and convenient test system for the determination of a number of different proteins on the same instrument. An optimized test system for turbidimetry and nephelometry should comprise high-quality antibodies, calibrators, controls, and buffers and a protocol with detailed parameter settings in order to program the instrument correctly. A good user program takes full advantage of the optimal reading principles for the different instruments. This implies--for all suitable instruments--sample preincubation followed by real sample blanking, which automatically corrects for initial turbidity in the sample. Likewise it is recommended to measure the reagent blank, which represents any turbidity caused by the antibody itself. By correcting all signals with these two blank values the best possible signal is obtained for the specific analyte. An optimized test system should preferably offer a wide measuring range combined with a wide security range, which for the user means few re-runs and maximum security against antigen excess. A non-linear calibration curve based on six standards is obtained using a suitable mathematical fitting model, which normally is part of the instrument software.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831625     DOI: 10.1515/CCLM.2001.175

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Authors:  Christine E Bulawa; Stephen Connelly; Michael Devit; Lan Wang; Charlotte Weigel; James A Fleming; Jeff Packman; Evan T Powers; R Luke Wiseman; Theodore R Foss; Ian A Wilson; Jeffery W Kelly; Richard Labaudinière
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Development and validation of 14 human serum protein assays on the Roche cobas® c 501.

Authors:  Thomas B Ledue; Marilyn F Collins
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite automated turbidimetric analyzer.

Authors:  Marina Garcia-Prat; Gemma Vila-Pijoan; Susana Martos Gutierrez; Guadalupe Gala Yerga; Esther García Guantes; Mónica Martínez-Gallo; Andrea Martín-Nalda; Pere Soler-Palacín; Manuel Hernández-González
Journal:  J Clin Lab Anal       Date:  2018-03-30       Impact factor: 2.352

Review 4.  Diagnoses Based on C-Reactive Protein Point-of-Care Tests.

Authors:  Miroslav Pohanka
Journal:  Biosensors (Basel)       Date:  2022-05-17

5.  Evaluation of INSTAND e.V.'s external quality assessment for C-reactive protein and procalcitonin.

Authors:  Nathalie Wojtalewicz; Ingo Schellenberg; Klaus-Peter Hunfeld
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.